Clinical Trial Update: CorPath® GRX Neuro Study [NA]

View source ↗

Summary

The CorPath GRX Neuro study sponsored by Corindus Inc. has completed and posted results for intracranial aneurysm and subarachnoid hemorrhage indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracranial Aneurysm
• Subarachnoid Hemorrhage

Drugs mentioned

• CorPath GRX

Snippet

Sponsor: Corindus Inc. | Conditions: Intracranial Aneurysm, Subarachnoid Hemorrhage | NA | Status: COMPLETED | Results posted: 2025-03-06